Curated News
By: NewsRamp Editorial Staff
June 11, 2026
LataMed AI Evaluates Cashea Payment Integration for Healthcare
TLDR
- LataMed AI's potential Cashea integration could boost patient acquisition and platform growth, giving it a competitive edge in Latin America's healthcare market.
- LataMed AI is evaluating a technical and commercial process to integrate Cashea's buy-now-pay-later system into its healthcare platform to reduce upfront costs.
- LataMed AI aims to improve healthcare access by enabling installment payments, helping patients afford private care and enhancing well-being in Latin America.
- LataMed AI is exploring a buy-now-pay-later option with Cashea for healthcare services, making medical care more affordable in Venezuela.
Impact - Why it Matters
This news matters because it highlights a potential solution to a major barrier in healthcare access: upfront costs. If LataMed AI successfully integrates Cashea's installment payment system, it could enable more patients in Venezuela and across Latin America to afford private healthcare services, leading to earlier treatment, better health outcomes, and reduced strain on public health systems. For investors, this move could drive platform growth and adoption, positioning LataMed AI as a key player in the digital health market in emerging economies.
Summary
LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, has announced the initiation of an evaluation process to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later financial technology platform in Venezuela. The proposed initiative aims to reduce upfront financial barriers for patients seeking access to private healthcare services, including consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem. By improving payment accessibility, the company believes it can enhance patient engagement, increase healthcare utilization, and drive broader platform adoption in Latin America.
Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., emphasized that financial accessibility is a critical component of healthcare delivery, and this evaluation aligns with the company's strategy to combine artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a scalable healthcare marketplace. The company has not yet entered into a definitive commercial agreement, and any integration remains subject to further discussions, technical implementation, regulatory review, and customary business conditions. LataMed AI intends to provide updates as material developments occur.
LataMed AI Corp. focuses on building telehealth infrastructure, healthcare coordination tools, analytics, and AI-enabled solutions for emerging markets, with an initial focus on Latin America. The company’s stock trades on the OTC under the ticker LMED. For more information, visit the company’s website at https://latamed.ai and review its filings with the SEC. The original release can be viewed on NEWMEDIAWIRE.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, LataMed AI Evaluates Cashea Payment Integration for Healthcare
